Oya Itil
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Oya Itil has a total of 133 co-authors. Here are the top co-authors by number of shared publications:
- Hasan Bayram
Koç University Research Center for Translational Medicine (KUTTAM), Koç University School of Medicine, Istanbul, Türkiye
4 shared publications - Seval Kul
Department of Biostatistics, Faculty of Medicine, Gaziantep University, Gaziantep 27310, Türkiye
4 shared publications - Nurdan Kokturk
Department of Pulmonary Diseases, Faculty of Medicine, Gazi University, Ankara, Turkey
3 shared publications - Pelin Duru Çetinkaya
Department of Pulmonary Medicine, Faculty of Medicine, Cukurova University, Adana 01790, Türkiye
3 shared publications - Abdullah Sayiner
Department of Pulmonology, İzmir University of Economics Faculty of Medicine, İzmir, Turkey
2 shared publications - Begüm Ergan
Department of Pulmonary and Critical Care, Dokuz Eylül University School of Medicine, İzmir, Turkey
2 shared publications
Latest Publications
- Open Access
Comparative transcriptomic analyses of peripheral blood mononuclear cells of patients with non-pneumonia and severe pneumonia at 1 year-Long-COVID-19
Long-COVID-19 manifests as a multisystemic condition with varied symptoms lingering beyond three weeks of acute SARS-CoV-2 infection, though its underlying mechanisms remain elusive. Aiming to decipher the long-term molecular impacts of COVID-19, we conducted a transcriptomic analysis on PBMCs from 1-year post-covid patients, including individuals without pneumonia (NP, n=10), those with severe pneumonia (SP, n=11), and healthy controls (C, n=13). Our extensive RNA sequencing revealed 4843 differentially expressed genes (DEGs) and 1056 differentially expressed long non-coding RNAs (DElncRNAs) in “C vs NP,” 1651 DEGs and 577 DElncRNAs in “C vs SP,” 954 DEGs and 148 DElncRNAs in “NP vs SP,” with 291 DEGs and 70 DElncRNAs shared across all groups. We identified 14 hub genes from 291 DEGs, with functional enrichment analysis showing upregulated DEGs mainly linked to inflammation and osteoclast differentiation, and downregulated DEGs to viral infections and immune responses. These hub genes play central roles in inflammatory and immune processes and are significantly associated with pneumonitis and diverse lung diseases. Investigations revealed unique immune cell signatures across DEG categories, associating upregulated DEGs with neutrophils and monocytes, and downregulated DEGs with CD4 memory effector T cells. Analysis of 14 hub genes showed notable upregulation in the no pneumonia group versus healthy controls, displaying complex patterns in the severe pneumonia group. Our study uncovered potential idiopathic pulmonary fibrosis signals in Long-COVID-19 patients’ PBMC transcriptome, highlighting the urgency for thorough monitoring and extended research to understand COVID-19’s lasting effects. This study sheds light on COVID-19’s transcriptomic changes and potential lasting effects, guiding future research and therapeutic approaches for Long-COVID-19.
Open AccessComparative transcriptomic analyses of peripheral blood mononuclear cells of patients with non-pneumonia and severe pneumonia at 1 year-Long-COVID-19
Long-COVID-19 manifests as a multisystemic condition with varied symptoms lingering beyond three weeks of acute SARS-CoV-2 infection, though its underlying mechanisms remain elusive. Aiming to decipher the long-term molecular impacts of COVID-19, we conducted a transcriptomic analysis on PBMCs from 1-year post-covid patients, including individuals without pneumonia (NP, n=10), those with severe pneumonia (SP, n=11), and healthy controls (C, n=13). Our extensive RNA sequencing revealed 4843 differentially expressed genes (DEGs) and 1056 differentially expressed long non-coding RNAs (DElncRNAs) in “C vs NP,” 1651 DEGs and 577 DElncRNAs in “C vs SP,” 954 DEGs and 148 DElncRNAs in “NP vs SP,” with 291 DEGs and 70 DElncRNAs shared across all groups. We identified 14 hub genes from 291 DEGs, with functional enrichment analysis showing upregulated DEGs mainly linked to inflammation and osteoclast differentiation, and downregulated DEGs to viral infections and immune responses. These hub genes play central roles in inflammatory and immune processes and are significantly associated with pneumonitis and diverse lung diseases. Investigations revealed unique immune cell signatures across DEG categories, associating upregulated DEGs with neutrophils and monocytes, and downregulated DEGs with CD4 memory effector T cells. Analysis of 14 hub genes showed notable upregulation in the no pneumonia group versus healthy controls, displaying complex patterns in the severe pneumonia group. Our study uncovered potential idiopathic pulmonary fibrosis signals in Long-COVID-19 patients’ PBMC transcriptome, highlighting the urgency for thorough monitoring and extended research to understand COVID-19’s lasting effects. This study sheds light on COVID-19’s transcriptomic changes and potential lasting effects, guiding future research and therapeutic approaches for Long-COVID-19.
- Open Access
- 1 May 2023
- Published by Galenos Yayinevi in Thoracic Research and Practice
- Vol. 24 (3) , 157-164
Facing Pandemic: Burnout in Nurses in Turkey
Burnout,COVID-19,nurses,pandemic
- 1 May 2023
- Published by Galenos Yayinevi in Thoracic Research and Practice
- Vol. 24 (3) , 157-164
Open AccessFacing Pandemic: Burnout in Nurses in Turkey
Burnout,COVID-19,nurses,pandemic
- 1 July 2021
- Published by Elsevier in Respiratory Medicine
- Vol. 183, 106433
The predictors of COVID-19 mortality in a nationwide cohort of Turkish patients
- 1 July 2021
- Published by Elsevier in Respiratory Medicine
- Vol. 183, 106433
The predictors of COVID-19 mortality in a nationwide cohort of Turkish patients
- 7 April 2021
- Published by Galenos Yayinevi in Turkish Thoracic Journal
- Vol. 22 (2) , 137-141
Excess Mortality During COVID-19 Pandemic in Istanbul
Excess mortality,coronavirus disease 2019,pandemic,Turkey
- 7 April 2021
- Published by Galenos Yayinevi in Turkish Thoracic Journal
- Vol. 22 (2) , 137-141
Excess Mortality During COVID-19 Pandemic in Istanbul
Excess mortality,coronavirus disease 2019,pandemic,Turkey
- 10 December 2020
- Published by Galenos Yayinevi in Turkish Thoracic Journal
- Vol. 21 (6) , 419-432
COVID-19 Pandemic and the Global Perspective of Turkish Thoracic Society
COVID-19 pandemic,Turkish Thoracic Society,social determinants of health,national lung health,clinical trials
- 10 December 2020
- Published by Galenos Yayinevi in Turkish Thoracic Journal
- Vol. 21 (6) , 419-432
COVID-19 Pandemic and the Global Perspective of Turkish Thoracic Society
COVID-19 pandemic,Turkish Thoracic Society,social determinants of health,national lung health,clinical trials